Are people with HIV and HCV co-infection who are cured of hepatitis C with DAAs at increased risk for liver cancer?
New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands
Curing hepatitis C reduces the risk of diabetes & kidney failure in people with HIV/HCV co-infection
Liver cirrhosis and decompensation still on the rise among people with hepatitis C
Is DAA treatment for hepatitis C reducing the need for liver transplants?
Sofosbuvir-based therapy achieves excellent SVR12 rates among people who inject drugs in Ukraine
Sofosbuvir/ledipasvir is effective for people with HIV/HCV co-infection in real-world clinical practice
Grazoprevir triple regimen demonstrates high cure rates, even for hard-to-treat people
People with HIV/HCV co-infection see good cure rates in real-world practice in Madrid
